RecruitingPhase 2NCT05985161
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Studying Nephroblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Michael Ortiz, MDMemorial Sloan Kettering Cancer Center
- Intervention
- Selinexor(drug)
- Enrollment
- 45 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2029
Study locations (15)
- Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California, United States
- Stanford Medicine Children's Health (Data Collection Only), Palo Alto, California, United States
- Children's National Hospital (Data Collection Only), Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta (Data Collection and Specimen Analysis), Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicag, Chicago, Illinois, United States
- Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States
- Washington University, St Louis, Missouri, United States
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States
- Cincinnati Children's Hospital Medical Center (Data collection only), Cincinnati, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05985161 on ClinicalTrials.govOther trials for Nephroblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06401330A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Children's Oncology Group
- RECRUITINGPHASE1, PHASE2NCT05384821Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)Centre Oscar Lambret
- RECRUITINGPHASE2NCT04968990Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam IrradiationSt. Jude Children's Research Hospital
- RECRUITINGNCT04423484Therapeutic Recommendations for NephroblastomaFrench Africa Pediatric Oncology Group